Moberg Pharma AB (publ) (MOB) — Cash Flow-to-Debt Ratio
Moberg Pharma AB (publ) (MOB) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2025, meaning its operating cash flow of Skr1.52 Million could theoretically repay 0% of its total liabilities (Skr17.04 Million) in one year. See MOB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Moberg Pharma AB (publ) Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Moberg Pharma AB (publ) across 18 annual periods. Also explore Moberg Pharma AB (publ) annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Moberg Pharma AB (publ) (2008–2025)
Year-by-year debt coverage analysis for Moberg Pharma AB (publ). For market capitalisation and broader financial context, see Moberg Pharma AB (publ) market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.03x | Skr-17.49 Million | Skr17.04 Million | ▼ -20.0% |
| 2024 | -0.85x | Skr-16.47 Million | Skr19.27 Million | ▲ +38.2% |
| 2023 | -1.38x | Skr-33.20 Million | Skr24.01 Million | ▼ -153.3% |
| 2022 | -0.55x | Skr-16.84 Million | Skr30.84 Million | ▲ +39.9% |
| 2021 | -0.91x | Skr-15.30 Million | Skr16.84 Million | ▼ -158.0% |
| 2020 | -0.35x | Skr-29.93 Million | Skr85.00 Million | ▼ -321.9% |
| 2019 | 0.16x | Skr3.95 Million | Skr24.91 Million | ▲ +41.2% |
| 2018 | 0.11x | Skr73.89 Million | Skr657.60 Million | ▲ +40.1% |
| 2017 | 0.08x | Skr53.82 Million | Skr670.85 Million | ▲ +399.8% |
| 2016 | -0.03x | Skr-17.94 Million | Skr670.55 Million | ▼ -103.9% |
| 2015 | 0.69x | Skr30.72 Million | Skr44.63 Million | ▲ +138.4% |
| 2014 | 0.29x | Skr16.16 Million | Skr55.97 Million | ▲ +742.7% |
| 2013 | -0.04x | Skr-3.15 Million | Skr70.11 Million | ▼ -148.6% |
| 2012 | 0.09x | Skr9.48 Million | Skr102.53 Million | ▲ +116.1% |
| 2011 | -0.58x | Skr-9.02 Million | Skr15.67 Million | ▲ +77.9% |
| 2010 | -2.60x | Skr-30.41 Million | Skr11.69 Million | ▲ +47.6% |
| 2009 | -4.96x | Skr-25.26 Million | Skr5.09 Million | ▼ -4.7% |
| 2008 | -4.74x | Skr-34.89 Million | Skr7.36 Million | — |